Yes, it does; however, litigation risk is hard to quantify, so I don’t know whether Bayer’s valuation has dropped sufficiently to discount the future Roundup judgments and settlements.
p.s. Monsanto was one of my largest positions for many years because ag biotech is perhaps the premiere beneficiary of The Global Demographic Tailwind.